Dallas, TX, January 12, 2017 --(PR.com
)-- Global intra-uterine contraceptive devices market is expected to reach USD 4.9 billion by 2024 from USD 3.68 billion in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The market is segmented on the basis of product, end user and geography.
On the basis of product the market is segmented into Hormonal IUCD, Copper IUCD.
Request for sample pages: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/
On the basis of end users the market is segmented into hospitals, gynecology clinics, and community healthcare. In 2017, the hospitals segment dominates the global intra-uterine contraceptive (IUCD) devices market with more than 49.5% market share.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Read more: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/
The global intra-uterine contraceptive devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of intra-uterine devices market for global, Europe, North America, Asia Pacific and Rest of the World.
Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed among other vernacular players.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.